We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWT icon
4001
NewtekOne
NEWT
$428M
$61K ﹤0.01%
+1,744
New +$54.8K
OPY icon
4002
Oppenheimer Holdings
OPY
$1.14B
$61K ﹤0.01%
1,200
-6,557
-85% -$316K
STXS icon
4003
Stereotaxis
STXS
$126M
$61K ﹤0.01%
6,279
-30,678
-83% -$242K
URE icon
4004
ProShares Ultra Real Estate
URE
$57.8M
$61K ﹤0.01%
+687
New +$57.4K
CSSE
4005
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$61K ﹤0.01%
1,454
-4,081
-74% -$143K
AMSC icon
4006
American Superconductor
AMSC
$1.42B
$60K ﹤0.01%
3,483
-26,903
-89% -$430K
IHDG icon
4007
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.22B
$60K ﹤0.01%
+1,362
New +$58.8K
INSW icon
4008
International Seaways
INSW
$4.76B
$60K ﹤0.01%
3,102
-17,486
-85% -$340K
LAB icon
4009
Standard BioTools
LAB
$340M
$60K ﹤0.01%
9,601
-52,254
-84% -$279K
LXRX icon
4010
Lexicon Pharmaceuticals
LXRX
$1.03B
$60K ﹤0.01%
13,250
-28,378
-68% -$137K
OFLX icon
4011
Omega Flex
OFLX
$297M
$60K ﹤0.01%
411
-2,022
-83% -$305K
ICBK
4012
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$60K ﹤0.01%
1,766
-2,254
-56% -$56.8K
BFST icon
4013
Business First Bancshares
BFST
$1.04B
$59K ﹤0.01%
2,562
-13,681
-84% -$324K
CRNT icon
4014
Ceragon Networks
CRNT
$197M
$59K ﹤0.01%
15,764
-33,636
-68% -$119K
GNW icon
4015
CALL
Genworth Financial
GNW
$3.76B
$59K ﹤0.01%
15,000
RMBS icon
4016
PUT
Rambus
RMBS
$9.87B
$59K ﹤0.01%
2,500
PRVB
4017
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$59K ﹤0.01%
7,016
+6,698
+2,106% +$54K
BRY
4018
DELISTED
Berry Corp
BRY
$58K ﹤0.01%
8,749
-61,551
-88% -$389K
EFT
4019
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$58K ﹤0.01%
4,000
EPM icon
4020
Evolution Petroleum
EPM
$132M
$58K ﹤0.01%
11,683
-14,261
-55% -$56K
KARS icon
4021
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$76.9M
$58K ﹤0.01%
1,245
+695
+126% +$29.7K
IMDX
4022
Insight Molecular Diagnostics
IMDX
$150M
$58K ﹤0.01%
509
-4,974
-91% -$486K
PAWZ icon
4023
ProShares Pet Care ETF
PAWZ
$34M
$58K ﹤0.01%
+720
New +$55.6K
RODM icon
4024
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.62B
$58K ﹤0.01%
+1,895
New +$58.8K
TRNS icon
4025
Transcat
TRNS
$799M
$58K ﹤0.01%
1,020
-4,870
-83% -$254K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.